ArticleExploration of targeted anti-tumor therapy2024
Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action.
Minghua Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.